603718.SHG Shanghai Hile Bio-tech

Healthcare Pharmaceuticals Shanghai Stock Exchange
2.96 CNY
Close of Nov 4, 2026
2.57 7.38
Market cap
CNY 1.92B
P/E
-
P/B
2.14x
ROE
3.2%
Dividend yield
6.36%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603718.SHG undervalued?

Graham number

The Graham number of Shanghai Hile Bio-tech cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Hile Bio-tech fundamental analysis

No fundamental analysis for Shanghai Hile Bio-tech yet.

Shanghai Hile Bio-tech stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Hile Bio-tech

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The company offers biochemistry reagents, immunoturbidimetric latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent assay reagents, and re…

Full company profile